U.S. Markets open in 1 hr 52 mins

MusclePharm to Present at the 2013 Southern California Investor Conference

DENVER, CO--(Marketwired - Aug 2, 2013) - MusclePharm Corporation ( OTCQB : MSLP ), a fast growing company that develops and markets sports nutritional supplements which address active lifestyles, announced today it will present at the 2013 Southern California Investor Conference. The conference will be held on Thursday, August 8, 2013 at the Island Hotel in Newport Beach, California. 

MusclePharm's co-Chairman and Executive Vice President, John Bluher, will present on behalf of the Company on August 8th at Noon PDT in Room 3. Investors interested in scheduling a one-on-one meeting at the conference with Mr. Bluher should contact Bob Prag at The Del Mar Consulting Group, Inc. at 858-794-9500 or bprag@delmarconsulting.com.

A live audio webcast of the presentation will be broadcast via the Internet. Those interested in listening to the live webcast may access it at: http://psevents.net/002/00271/2013-SCIC/?contid=Track-3.


Founded in 2008 by former NFL player Brad Pyatt, MusclePharm is a healthy lifestyle company that develops and manufactures scientific and safe nutritional supplements. The company's products are designed for Active Lifestyles who seek muscle building, weight maintenance and general fitness through an internationally recognized daily nutritional supplement regimen. The products are formulated through a six-stage research process designed by leading nutritional scientists at the MusclePharm Sports Science & Research Center in Denver. MusclePharm's products are sold in more than 110 countries and available in 10,500+ U.S. retail outlets, including Dick's Sporting Goods, 24 Hour Fitness, Bally's, GNC, Vitamin Shoppe and Vitamin World. MusclePharm products also are sold globally through more than 100 online channels, including Bodybuilding.com, Amazon.com and Vitacost.com.

For more information, visit www.MusclePharm.com. Follow the company at www.Facebook.com/MusclePharm and www.Twitter.com/MusclePharm.


This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended. Statements that are not a description of historical facts constitute forward-looking statements and may often, but not always, be identified by the use of such words as "expects", "anticipates", "intends", "estimates", "plans", "potential", "possible", "probable", "believes", "seeks", "may", "will", "should", "could" or the negative of such terms or other similar expressions. Actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in the Company's business. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's Annual Report on Form 10-K/A for the fiscal year ended December 31, 2011, the Company's Quarter Reports on Form 10-Q and other filings submitted by the Company to the SEC, copies of which may be obtained from the SEC's website at www.sec.gov. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and the Company undertakes no obligation to revise or update this release to reflect events or circumstances after the date hereof.